Status:
COMPLETED
Colorectal Cancer Screening Based on Predicted Risk
Lead Sponsor:
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
Conditions:
Colorectal Cancer
Eligibility:
All Genders
50-69 years
Phase:
NA
Brief Summary
The primary objective is to study the effect of communicating individual CRC risk score and screening recommendations on appropriate screening uptake at six months in individuals at low, moderate and ...
Detailed Description
Colorectal cancer (CRC) can be effectively prevented by screening. Risk to develop CRC within 15 years is related to increasing age, sex, family history, and lifestyle and, thus, can vary from \<1% to...
Eligibility Criteria
Inclusion
- Aged between 50 and 69;
- Residents of the Canton of Vaud;
- Have signed an informed consent (paper or electronic).
Exclusion
- Current CRC symptoms;
- Personal CRC history;
- In colonoscopy surveillance for follow-up of high-risk polyp(s);
- Inflammatory bowel disease;
- Having done a colonoscopy within 9 years or a FIT within 1,5 years;
- Planning to leave Switzerland definitively within the next six months.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
515 Patients enrolled
Trial Details
Trial ID
NCT05357508
Start Date
May 1 2022
End Date
December 31 2023
Last Update
May 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Primary Care and Public Health (Unisante)
Lausanne, Canton of Vaud, Switzerland, 1011